Driving deep collaboration between a global pharmaceutical giant and a clinical research organisation
For 18 months, a high profile global study for a critical new product was struggling to meet timelines and essential patient recruitment for the launch was running 60% behind target
Being delivered in partnership with a Clinical Research Organisation, the stakes were high for both parties; potentially jeopardising long term strategic ambitions at a senior level. Relationships had broken down within the team and frustration was high, threatening the study at large. Belief in the study was at an all-time low of; “this is impossible to recover”
Both organisations had taken steps to get the study back on track, but because of significant doubt, blame and lack of trust, people on both sides resigned to the project not being delivered.
Breakthroughs needed:
1. Pre-work dialogue with individual stakeholders involved:
2. Strategic partnering programme (workshop based)
3. Coaching of key people in study team between meetings to resolve live setbacks in the day to day study operations.
4. Both companies appointed alliance managers who held them jointly accountable for their commitments with a direct line to senior management.